Evidence map›Paper›PMID 28750641›Full record

ArticleCritical care (London, England)2017

Metabolome alterations in severe critical illness and vitamin D status.

Jessica Lasky-Su, Amber Dahlin, Augusto A Litonjua, Angela J Rogers, Michael J McGeachie, Rebecca M Baron, Lee Gazourian, Diana Barragan-Bradford, Laura E Fredenburgh, Augustine M K Choi and 4 more

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. High-resolution plasma metabolomics and thiamine status in critically Ill adult patients.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  11. Maternal vitamin D-related metabolome and offspring risk of asthma outcomes.The Journal of allergy and clinical immunology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Jessica Lasky-SuChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Amber DahlinChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Augusto A LitonjuaPulmonary and Critical Care Division, Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Angela J RogersPulmonary & Critical Care Medicine, Stanford University Medical Center, Stanford, CA, USA.
Michael J McGeachieChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Rebecca M BaronPulmonary and Critical Care Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Lee GazourianPulmonary and Critical Care Medicine, Lahey Hospital & Medical Center, Burlington, MA, USA.
Diana Barragan-BradfordPulmonary and Critical Care Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Laura E FredenburghPulmonary and Critical Care Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Augustine M K ChoiDepartment of Medicine, New York-Presbyterian Hospital, New York, NY, USA.
Kris M MogensenDepartment of Nutrition, Brigham and Women's Hospital, Boston, MA, USA.
Sadeq A QuraishiDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Karin AmreinDivision of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Kenneth B ChristopherChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. kbchristopher@bwh.harvard.edu.
Brigham and Women's Hospital · USLahey Hospital and Medical Center · USMassachusetts General Hospital · USMedical University of Graz · ATNewYork–Presbyterian Hospital · USStanford University · US

Funding

Training Program in Molecular and Integrative Physiological SciencesT32HL007118 · NHLBI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LU, QUAN · 1985 to 2025
$14.3M
Mesenchymal Stromal Cell Conditioning by Carbon MonoxideP01HL108801 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHOI, AUGUSTINE M · 2011 to 2015
$13.8M
Integrative Metabolomics of Asthma SeverityR01HL123915 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LASKY-SU, JESSICA A · 2014 to 2023
$7.0M
Heme oxygenase-1: Regulation and Function in CaveolaeR01HL079904 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHOI, MARY E · 2005 to 2014
$2.9M
Role of NOS2 in Sepsis-Induced ARDSR01HL091957 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BARON, REBECCA M · 2009 to 2013
$2.2M
Translational Genetics and Genomics of Airways DiseasesK12HL089990 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISS, SCOTT T · 2007 to 2012
$1.9M
The Inflammasome: A Novel Biomarker in ALI/ARDSR01HL112747 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BARON, REBECCA M · 2012 to 2015
$1.8M
CELL AND MOLECULAR BIOLOGY OF BLOOD AND ITS DISORDERST32HL007680 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI STOSSEL, THOMAS PETER · 1989 to 2009
$1.0M
Pharmacokinetics and metabolomics of vitamin D supplementation in critical illnessR01GM115774 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI CHRISTOPHER, KENNETH BRUCE · 2016 to 2018
$940k
Role of microRNA molecules in therapeutic response to leukotriene modifying agents in asthmaK01HL130629 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DAHLIN, AMBER · 2016 to 2020
$818k
Role of Cyclooxygenase-2-derived Prostanoids in Polymicrobial SepsisK08GM083207 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI FREDENBURGH, LAURA ELIZABETH · 2008 to 2012
$752k
NHLBI NIH HHS K01 HL130629NHLBI NIH HHS K12 HL089990NHLBI NIH HHS P01 HL108801NHLBI NIH HHS R01 HL079904NHLBI NIH HHS R01 HL091957NHLBI NIH HHS R01 HL112747NHLBI NIH HHS R01 HL123915NHLBI NIH HHS T32 HL007118NHLBI NIH HHS T32 HL007680NIGMS NIH HHS K08 GM083207NIGMS NIH HHS R01 GM115774
6 · The paper itself

Abstract

backgroundMetabolic homeostasis is substantially disrupted in critical illness. Given the pleiotropic effects of vitamin D, we hypothesized that metabolic profiles differ between critically ill patients relative to their vitamin D status.

methodsWe performed a metabolomics study on biorepository samples collected from a single academic medical center on 65 adults with systemic inflammatory response syndrome or sepsis treated in a 20-bed medical ICU between 2008 and 2010. To identify key metabolites and metabolic pathways related to vitamin D status in critical illness, we first generated metabolomic data using gas and liquid chromatography mass spectroscopy. We followed this by partial least squares-discriminant analysis to identify individual metabolites that were significant. We then interrogated the entire metabolomics profile using metabolite set enrichment analysis to identify groups of metabolites and pathways that were differentiates of vitamin D status. Finally we performed logistic regression to construct a network model of chemical-protein target interactions important in vitamin D status.

resultsMetabolomic profiles significantly differed in critically ill patients with 25(OH)D ≤ 15 ng/ml relative to those with levels >15 ng/ml. In particular, increased 1,5-anhydroglucitol, tryptophan betaine, and 3-hydroxyoctanoate as well as decreased 2-arachidonoyl-glycerophosphocholine and N-6-trimethyllysine were strong predictors of 25(OH)D >15 ng/ml. The combination of these five metabolites led to an area under the curve for discrimination for 25(OH)D > 15 ng/ml of 0.82 (95% CI 0.71-0.93). The metabolite pathways related to glutathione metabolism and glutamate metabolism are significantly enriched with regard to vitamin D status.

conclusionVitamin D status is associated with differential metabolic profiles during critical illness. Glutathione and glutamate pathway metabolism, which play principal roles in redox regulation and immunomodulation, respectively, were significantly altered with vitamin D status.

Indexed as

Academic Medical CentersAdultAgedAPACHEBostonCohort StudiesCritical IllnessDiscriminant AnalysisFemaleHumansLogistic ModelsMaleMetabolomeMiddle AgedRegistriesSystemic Inflammatory Response SyndromeVitamin DCritical illnessHomeostasisMetaboliteMetabolomicsVitamin D

Identifiers

PMID28750641
PMCPMC5532782
OpenAlexW2740750635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.